Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-275291 (rebimastat) + Paclitaxel/Carboplatin in Advanced NSCLC
NCT00006229Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Apr 2000
- Primary completion
- Dec 2003
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of rebimastat in non-small cell lung cancer (NSCLC), sponsored by Canadian Cancer Trials Group. Started Apr 2000; status: completed.
02
Drugs
rebimastat
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00006229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006229.